Table 3. Estimates of dengue overall multiplier for outpatients in Puerto Rico: 2005 to 2010.
| MAa | DOa | |||||||
|---|---|---|---|---|---|---|---|---|
| Year | Mean | Std Dev | 2.5th percentile | 97.5th percentile | Mean | Std Dev | 2.5th percentile | 97.5th percentile |
| 2005 | 84.46 | 25.11 | 43.55 | 129.67 | 24.33 | 9.47 | 9.24 | 42.48 |
| 2006 | 95.36 | 30.21 | 46.58 | 155.34 | 27.26 | 11.98 | 9.16 | 53.35 |
| 2007 | 80.75 | 24.64 | 40.75 | 127.78 | 23.19 | 9.67 | 8.20 | 43.60 |
| 2008 | 115.06 | 37.29 | 55.31 | 191.61 | 32.85 | 15.00 | 10.60 | 66.91 |
| 2009 | 89.10 | 27.96 | 43.84 | 143.70 | 25.49 | 10.96 | 8.90 | 49.50 |
| 2010 | 74.55 | 22.43 | 37.99 | 116.68 | 21.41 | 8.59 | 7.93 | 38.74 |
a: MA sub-model = “Medically Attended (MA),” which includes all patients who either had a completed Dengue Case Information Form (DCIF), or had some indication in their medical records (such as specimens sent to a laboratory for dengue testing) as potentially having a clinical case of dengue. In the second sub-model, labeled “DCIF Only (DO)” we included only those patients (in or out) definitively recorded as potential dengue case on a DCIF. See text for further details.